Approved Work Item
ISO/AWI 26626
Surgical implants - Biobased materials — Characterization and evaluation of recombinant collagen
Reference number
ISO/AWI 26626
Edition 1
© ISO 2026
Approved Work Item
Under development
A working group has prepared a draft.

Abstract

This document specifies the requirements and methods for characterization and evaluation of recombinant collagen as starting material for implants, including requirements for quality assessment and quality control, test items and corresponding methods, packaging and storage. This document is intended to be used for the quality assessment and quality control of recombinant collagen. This document is not applied for recombinant collagen which will be used as medicine for the treatment of collagen related genetic diseases, such like recombinant collagen VII for the treatment of Epidermolysis bullosa.

General information

  • Status
     : Under development
    Stage
    : New project registered in TC/SC work programme [20.00]
  • Edition
     : 1
  • Technical Committee :
    ISO/TC 150/SC 1
  • RSS updates

Life cycle

Sustainable Development Goals

This standard contributes to the following Sustainable Development Goal

3
Good Health and Well-being

Got a question?

Check out our Help and Support

  2. Store
  3. Store
  4. ICS
  5. ISO/AWI 26626